Counsel patients regarding the potential risk for MTC with the use of Ozempic and inform them of symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness)
Inject subcutaneously or intramuscularly
The critical distinction of plasma clearance and therapeutic duration is that the biological repair cascades BPC-157 initiates (angiogenesis, collagen synthesis, and fibroblast activation) persist 24 to 48 hours beyond full plasma clearance
In some cases, the cause is unknown
Further, conducting research using BPC-157 nasal spray may lead to eye, nose, or throat irritation, sneezing, coughing, and other transitory complaints